Fingerprint
Dive into the research topics of 'Schedule Dependent Efficacy of Gefitinib and Docetaxel for Bladder Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Schedule Dependent Efficacy of Gefitinib and Docetaxel for Bladder Cancer
Wassim Kassouf, Tony Luongo, Gordon Brown, Liana Adam, Colin P.N. Dinney
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations